Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?page=14&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?page=14&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?page=14&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (60.420)
131
A study to investigate the efficacy and safety of Aramchol in patients with a form of fatty liver disease. : A Phase 3, Multinational, Multicenter, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH)The ARMOR Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
132
Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors : Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
133
A study to test activity and safety of treatment with avelumab in combination with cetuximab in patients suffering from non-operable squamous cell skin cancer. : A single arm phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab in combination with cetuximab in subjects with unresectable stage III or stage IV cutaneous squamous cell carcinoma (cSCC) - AliCe (Avelumab in combination with cetuximab)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
134
Tralokinumab monotherapy for adolescent subjects with moderate-to-severe atopic dermatitis - ECZTRA 6 : A randomised, double-blind, placebo-controlled, parallel-group, multi-centre trial to evaluate the efficacy, safety, and tolerability of tralokinumab monotherapy in adolescent subjects with moderate-to-severe atopic dermatitis who are candidates for systemic therapy - ECZTRA 6 (ECZema TRAlokinumab trial no.6)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
135
Preventing Abnormal Glucose Tolerance and Diabetes with an Antibody in Relatives at Risk for the Disease : CTLA-4Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
136
A ROLLOVER PROTOCOL FOR PATIENTS WHO RECEIVED TREMELIMUMAB (CP-675,206) IN OTHER PROTOCOLS : A ROLLOVER PROTOCOL FOR PATIENTS WHO RECEIVED TREMELIMUMAB (CP-675,206) IN OTHER PROTOCOLS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
137
Impact of high dose of vitamin D in critically ill septic patients with vitamin D deficiency: the CaribDean study : Impact of high dose of cholecalciferol in critically ill septic patients with vitamin D deficiency: the CaribDean study - Carib'Dean
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
138
Blinded study on safety, tolerability and lumbar fusion efficacy of a single dose of Osteogrow (which comprises a protein called BMP6 mixed with the patients own blood to form a clot) in adult patients treated by spinal fusion (posterolateral lumbar interbody fusion, PLIF) for degenerative disc disease : Patient and evaluator blinded non-inferiority study on safety, tolerability and lumbar fusion efficacy of a single administration of Osteogrow (rhBMP6 in autologous blood coagulum (ABC) carrier) in adult patients treated by posterolateral lumbar interbody fusion (PLIF) for degenerative disc disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
139
Study to evaluate vibegron in men taking stable BPH medications who have overactive bladder symptoms : A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men with Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) - Vibegron in Men with BPH with OAB
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
140
A study to evaluate how safe MVA.HTI and ChAdOx1.HTI vaccines with vesatolimod are in participants with early treated HIV-1 infection. : A Phase IIa, randomized, double-blind, placebo-controlled, study of HIV-1 Vaccines MVA.HTI and ChAdOx1.HTI with TLR7 agonist vesatolimod (GS-9620), in early treated HIV-1 infection
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
9
10
11
12
13
14
15
16
17
18
19
Nächster »
[6042]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
60.420
Aufsätze
60.420
E-Artikel
60.420
E-Ressourcen
Zeitschriftentitel
60.420
WHO International Clinical Trials Registry Plat...
Thema
60.420
610
60.420
Recruitment Status: Authorised-recruitment may ...
60.420
Study Type: Interventional
23.556
Phase: Phase 3
15.068
Phase: Phase 2
4.508
Phase: Phase 4
3.278
Phase: Phase 1
152
Medical Condition: Multiple Myeloma MedDRA vers...
122
Medical Condition: Moderately to Severely Activ...
114
Medical Condition: Diabetes Mellitus, Type 2 Me...
88
Medical Condition: Atopic Dermatitis MedDRA ver...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
84
Medical Condition: Cystic Fibrosis MedDRA versi...
76
Medical Condition: Asthma MedDRA version: 20.0L...
68
Medical Condition: Myelofibrosis MedDRA version...
66
Medical Condition: Mild cognitive impairment (M...
64
Medical Condition: Chronic Obstructive Pulmonar...
64
Medical Condition: Moderately to Severely Activ...
64
Medical Condition: Multiple myeloma MedDRA vers...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
35.522
2020-
24.898
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
56.722
Englisch
1.244
Unbestimmt
1.058
Französisch
794
Spanisch
162
Finnisch
124
Deutsch
70
Schwedisch
58
Niederländisch
58
Italienisch
44
Dänisch
26
Galizisch
12
Ungarisch
10
Norwegisch
8
Tschechisch
6
Latein
4
Isländisch
2
Estnisch
2
Frisian
2
Hausa
2
Indonesisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...